SCHEMBL23790886

SCHEMBL23790886

CCC(C)OC1CC(COC(C)C)N(C(=O)CC(C)(C)C(C)(C)CC(=O)C(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19871862 0.91 — —
SCHEMBL20099250 0.84 — —
SCHEMBL25466905 0.82 — —
SCHEMBL22692680 0.81 — —
SCHEMBL23136552 0.79 HCRTR2 (0.32) —
SCHEMBL20099270 0.77 — —
SCHEMBL16248511 0.76 DPP4 (0.32) —
SCHEMBL24012450 0.74 — —
SCHEMBL21155008 0.74 CHRNB2 (0.32) —
SCHEMBL20016484 0.74 DPP4 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210277401-A1 Compositions and Methods for Modulating PKK Expression IONIS PHARMACEUTICALS, INC. (US) 2021-09-09 — — US disclosed
Send feedback